0000000000895166

AUTHOR

O. Tu¨ Reci

showing 1 related works from this author

220O Claudin 18.2 - a novel treatment target in the multicenter, randomized, phase II FAST study, a trial of epirubicin, oxaliplatin, and capecitabin…

2016

Oncologymedicine.medical_specialtybiologybusiness.industryCancerHematologyGastroesophageal Junctionmedicine.diseaseOxaliplatinCapecitabine03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesisInternal medicinebiology.proteinmedicine030212 general & internal medicineAntibodyClaudinbusinessIMAB362Epirubicinmedicine.drugAnnals of Oncology
researchProduct